| Financial Year |
March 31 2023 |
| Monetary Funds |
171,329,020.85 |
| Held-for-trading Financial Assets |
1,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
26,476,439.41 |
| Advances to Suppliers |
14,236,861.46 |
| Other Receivables |
1,847,373.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
443,858,429.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
37,699,757.70 |
| Total Current Assets |
697,563,626.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
70,551,172.82 |
| Investment Properties |
20,840,229.45 |
| Fixed Assetes |
531,949,214.47 |
| Under-construction Projects |
159,224,966.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
297,477,349.58 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
123,451,358.10 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
83,491.24 |
| Deferred Income Tax Assets |
380,959.13 |
| Other Non-Current Assets |
4,396,755.76 |
| Sub-Total of Non-Current Assets |
1,234,817,590.83 |
| Total Assets |
1,932,381,217.07 |
| Short-Term Loans |
575,603,041.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
29,500,000.00 |
| Accounts Payable |
187,463,372.85 |
| Accounts Received In Advance |
400,448.38 |
| Employee Compensation Payable |
18,378,326.06 |
| Taxes Payable |
2,250,605.30 |
| Interest Payable |
-- |
| Dividend Payable |
128,665.36 |
| Other payables |
151,055,474.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,633,697.80 |
| Other Current Liabilities |
5,143,128.08 |
| Sub-Total of Current Liabilities |
1,064,075,852.78 |
| Long-term Loans |
174,787,499.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
232,342,231.52 |
| Total Liabilities |
1,296,418,084.30 |
| Paid-In Capital(Or Share Stock) |
381,512,820.00 |
| Capital Surplus |
937,044,683.32 |
| Surplus Reserve |
63,694,424.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-702,841,330.50 |
| Minority Stockholder's Interest |
13,716,310.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
622,246,822.04 |
| Owner's Equity（Stockholder's Equity） |
635,963,132.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,932,381,217.07 |
